Related Experiment Video
Updated: Jun 6, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Genetic discovery: the prescription for chronic pain
1Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305, USA. mzheng@stanford.edu.
Abstract:
A recent publication that combined rat gene expression data and a human genetic association study has identified the first genetic risk factor for chronic pain in humans. In four of the five cohorts studied, there was a significant association of an allele within a gene (KCNS1) encoding a potassium channel (Kv9.1) with an increased risk for chronic pain. Identification of genetic risk factors for chronic pain could catalyze new advances in this difficult clinical area that has become a major public health problem. Genomic-medicine-based advances for chronic pain could include the development of a mechanism-based classification system for chronic pain, new treatment options, improved methods for treatment selection and targeted prevention strategies for high-risk individuals.
Related Concept Videos
Analgesia and Pain Management
Pharmacogenomics: Identification of New Drug Targets
Nociception
Pain
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview
